BVI Stock Analysis: Bureau Veritas | PA
Consulting Services | PA, France | Market Cap: 12.079m EUR | 12M Return: 0.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 24.4M
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Bureau Veritas SA is a French testing, inspection, and certification (TIC) company headquartered in Neuilly-sur-Seine, founded in 1828. It operates through six segments - Marine & Offshore; Agri-Food & Commodities; Industry; Buildings & Infrastructure; Certification; and Consumer Products - delivering services such as compliance auditing, laboratory testing, asset integrity management, technical control, and management system certification to clients in industries including oil and gas, construction, marine, automotive, aerospace, power, and the public sector.
The company belongs to the GICS Industrials / Research & Consulting Services sub-industry and operates in approximately 140 countries. The broader TIC sector is shaped by regulatory mandates, infrastructure spending, and the globalization of supply chains, with Bureau Veritas competing alongside other large international operators such as SGS and Intertek.
- Marine offshore revenue rises with oil and gas capex recovery
- Energy transition drives certification and offshore wind demand
- Strong euro pressures emerging market testing revenue margins
| Net Income: 588.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.21 > 1.0 |
| NWC/Revenue: 17.17% < 20% (prev 13.17%; Δ 4.00% < -1%) |
| CFO/TA 0.14 > 3% & CFO 966.7m > Net Income 588.0m |
| Net Debt (2.18b) to EBITDA (1.24b): 1.76 < 3 |
| Current Ratio: 1.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (445.7m) vs 12m ago -2.73% < -2% |
| Gross Margin: 23.95% > 18% (prev 72.54%; Δ -48.59% > 0.5%) |
| Asset Turnover: 90.70% > 50% (prev 88.06%; Δ 2.64% > 0%) |
| Interest Coverage Ratio: 9.20 > 6 (EBIT TTM 942.0m / Interest Expense TTM 102.4m) |
| A: 0.16 (Total Current Assets 3.31b - Total Current Liabilities 2.20b) / Total Assets 7.06b |
| B: 0.23 (Retained Earnings 1.66b / Total Assets 7.06b) |
| C: 0.13 (EBIT TTM 942.0m / Avg Total Assets 7.13b) |
| D: 0.32 (Book Value of Equity 1.71b / Total Liabilities 5.31b) |
| Altman-Z'' = 3.02 = A |
| DSRI: 0.97 (Receivables 1.94b/1.95b, Revenue 6.47b/6.34b) |
| GMI: 3.03 (GM 72.54% / 23.95%) |
| AQI: 0.99 (AQ_t 0.42 / AQ_t-1 0.42) |
| SGI: 1.02 (Revenue 6.47b / 6.34b) |
| TATA: -0.05 (NI 588.0m - CFO 966.7m) / TA 7.06b) |
| Beneish M = -1.21 (Cap -4..+1) = D |
As of July 15, 2026, the stock is trading at EUR 27.19 with a total of 809,275 shares traded. Over the past week, the price has changed by -0.11%, over one month by +4.10%, over three months by +1.40% and over the past year by +0.74%.
Current recommended Stop Loss: 26.10 (which is 4% or 2.2 ATR below the current price).
Bureau Veritas has no consensus analysts rating.
P/E Trailing = 20.7634
P/E Forward = 17.6056
P/S = 1.792
P/B = 6.9975
P/EG = 2.8421
Revenue TTM = 6.47b EUR
EBIT TTM = 942.0m EUR
EBITDA TTM = 1.24b EUR
Long Term Debt = 2.39b EUR (from longTermDebt, last quarter)
Short Term Debt = 347.9m EUR (from shortTermDebt, last quarter)
Debt = 3.55b EUR (from shortLongTermDebtTotal, last quarter) + Leases 465.6m
Net Debt = 2.18b EUR (calculated: Debt 3.55b - CCE 1.37b)
Enterprise Value = 14.3b EUR (12.1b + Debt 3.55b - CCE 1.37b)
Interest Coverage Ratio = 9.20 (Ebit TTM 942.0m / Interest Expense TTM 102.4m)
EV/FCF = 17.40x (Enterprise Value 14.3b / FCF TTM 819.7m)
FCF Yield = 5.75% (FCF TTM 819.7m / Enterprise Value 14.3b)
FCF Margin = 12.68% (FCF TTM 819.7m / Revenue TTM 6.47b)
Net Margin = 9.09% (Net Income TTM 588.0m / Revenue TTM 6.47b)
Gross Margin = 23.95% ((Revenue TTM 6.47b - Cost of Revenue TTM 4.92b) / Revenue TTM)
Gross Margin QoQ = 24.61% (prev 23.27%)
Tobins Q-Ratio = 2.02 (Enterprise Value 14.3b / Total Assets 7.06b)
Interest Expense / Debt = 2.88% (Interest Expense 102.4m / Debt 3.55b)
Taxrate = 30.37% (265.9m / 875.4m)
NOPAT = 655.9m (EBIT 942.0m * (1 - 30.37%))
Current Ratio = 1.50 (Total Current Assets 3.31b / Total Current Liabilities 2.20b)
Debt / Equity = 2.08 (Debt 3.55b / totalStockholderEquity, last quarter 1.71b)
Debt / EBITDA = 1.76 (Net Debt 2.18b / EBITDA 1.24b)
Debt / FCF = 2.67 (Net Debt 2.18b / FCF TTM 819.7m)
Total Stockholder Equity = 1.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.25% (Net Income 588.0m / Total Assets 7.06b)
RoE = 34.82% (Net Income TTM 588.0m / Total Stockholder Equity 1.69b)
RoCE = 23.10% (EBIT 942.0m / Capital Employed (Equity 1.69b + L.T.Debt 2.39b))
RoIC = 13.43% (NOPAT 655.9m / Invested Capital 4.88b)
WACC = 6.19% (E(12.1b)/V(15.6b) * Re(7.42%) + D(3.55b)/V(15.6b) * Rd(2.88%) * (1-Tc(0.30)))
Discount Rate = 7.42% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -74.09 | Cagr: -1.10%
[DCF] Terminal Value 74.95% ; FCFF base≈831.7m ; Y1≈810.4m ; Y5≈808.4m
[DCF] Fair Price = 23.58 (EV 12.7b - Net Debt 2.18b = Equity 10.5b / Shares 444.1m; r=8.35% [WACC [floored]]; 5y FCF grow -3.54% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 79.51 | Revenue CAGR: 15.52% | SUE: 0.00 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=1.53 | Chg30d=+0.02% | Revisions=+0% | GrowthEPS=+8.0% | GrowthRev=+4.3%
EPS next Year (2027-12-31): EPS=1.67 | Chg30d=+0.39% | Revisions=-17% | GrowthEPS=+8.7% | GrowthRev=+6.3%
[Analyst] Revisions Ratio: -10% (up=3, down=4)